Cargando…
A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramatic evolution in a patient with several risk f...
Autores principales: | Heitzmann, Edwige, Javelot, Hervé, Weiner, Luisa, Michel, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080510/ https://www.ncbi.nlm.nih.gov/pubmed/27818825 http://dx.doi.org/10.1155/2016/7031245 |
Ejemplares similares
-
Aripiprazole in Tardive Dyskinesia: Is it a Safe Choice?
por: Doval, Nimisha, et al.
Publicado: (2017) -
Tardive Dyskinesia: Treatment with Aripiprazole
por: Kang, Na-Ri, et al.
Publicado: (2011) -
A Case of Aripiprazole Induced Tardive Dyskinesia in a Neuroleptic-Naïve Patient with Two Years of Follow Up
por: Goyal, Rakesh, et al.
Publicado: (2014) -
Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report
por: Lamberti, Marco, et al.
Publicado: (2017) -
Tardive Dystonia Related with Aripiprazole
por: Kim, Sunghwan, et al.
Publicado: (2017)